Kitagawa M - Search Results

1

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y. Kitagawa M, et al. EMBO J. 1996 Dec 16;15(24):7060-9. EMBO J. 1996. PMID: 9003781 Free PMC article.

2

Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.

Higashi H, Suzuki-Takahashi I, Taya Y, Segawa K, Nishimura S, Kitagawa M. Higashi H, et al. Among authors: kitagawa m. Biochem Biophys Res Commun. 1995 Nov 13;216(2):520-5. doi: 10.1006/bbrc.1995.2653. Biochem Biophys Res Commun. 1995. PMID: 7488142

3

The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.

Suzuki-Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S, Okuyama A. Suzuki-Takahashi I, et al. Among authors: kitagawa m. Oncogene. 1995 May 4;10(9):1691-8. Oncogene. 1995. PMID: 7753545

4

Phosphorylation of E2F-1 by cyclin A-cdk2.

Kitagawa M, Higashi H, Suzuki-Takahashi I, Segawa K, Hanks SK, Taya Y, Nishimura S, Okuyama A. Kitagawa M, et al. Oncogene. 1995 Jan 19;10(2):229-36. Oncogene. 1995. PMID: 7838523

5

A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.

Kitagawa M, Higashi H, Takahashi IS, Okabe T, Ogino H, Taya Y, Hishimura S, Okuyama A. Kitagawa M, et al. Oncogene. 1994 Sep;9(9):2549-57. Oncogene. 1994. PMID: 8058318

Butyrolactone I also inhibited H1 histone phosphorylation in human WI38 cells and their G2/M progression. tsFT210 cells, a temperature-sensitive cdc2 mutant cell line, were synchronized at G2/M at a nonpermissive temperature, butyrolactone I inhibited the cell cycle …

Butyrolactone I also inhibited H1 histone phosphorylation in human WI38 cells and their G2/M progression. tsFT210 cells, a temperatur …

6

Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H, et al. Kitagawa M, et al. Oncogene. 1993 Sep;8(9):2425-32. Oncogene. 1993. PMID: 8395680

7

Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.

Higashi H, Suzuki-Takahashi I, Saitoh S, Segawa K, Taya Y, Okuyama A, Nishimura S, Kitagawa M. Higashi H, et al. Among authors: kitagawa m. Eur J Biochem. 1996 Apr 15;237(2):460-7. doi: 10.1111/j.1432-1033.1996.0460k.x. Eur J Biochem. 1996. PMID: 8647086 Free article.

8

Expression of p16INK4a suppresses the unbounded and anchorage-independent growth of a glioblastoma cell line that lacks p16INK4a.

Higashi H, Suzuki-Takahashi I, Yoshida E, Nishimura S, Kitagawa M. Higashi H, et al. Among authors: kitagawa m. Biochem Biophys Res Commun. 1997 Feb 24;231(3):743-50. doi: 10.1006/bbrc.1997.6181. Biochem Biophys Res Commun. 1997. PMID: 9070885

9

Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators.

Suzuki-Takahashi I, Higashi H, Yoshida E, Nishimura S, Kitagawa M. Suzuki-Takahashi I, et al. Among authors: kitagawa m. Biochem Biophys Res Commun. 1997 May 19;234(2):386-92. doi: 10.1006/bbrc.1997.6654. Biochem Biophys Res Commun. 1997. PMID: 9177281

10

[Cell-cycle regulation via phosphorylation of RB protein by cyclin-dependent kinase].

Kitagawa M, Taya Y. Kitagawa M, et al. Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1594-602. Tanpakushitsu Kakusan Koso. 1997. PMID: 9279086 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,650 results

Search Page